Synthetic Biologics, Inc. Soared
Fri, Mar 12, 2021 at 05:33 PM
Synthetic Biologics, Inc. (SYN:NYSEMKT) rocketted at $0.92, representing a gain of 29.7%. On Thu 11 Mar 21, SYN:NYSEMKT hit a New 2-Week High of $0.71. The stock got featured on our News Catalysts scanner on Thu 04 Mar 21 at 07:19 PM in the 'EARNINGS' category. From Thu 25 Feb 21, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Tue 05 Jan 21 at $1.7 with a volume of 360M+, and its share price has been moving sideways in recent weeks.
About Synthetic Biologics, Inc. (SYN:NYSEMKT)
Synthetic Biologics Inc is a late-stage biotechnology company focused on developing gut microbiome therapeutics. It is also developing monoclonal antibody therapies for the treatment of pertussis.
Top 10 Gainers:
- NLSP (NLSP:NASDAQ), 106.71%
- Entera Bio Ltd. (ENTX:NASDAQ), 70.79%
- Seelos Therapeutics, Inc. (SEEL:NASDAQ), 56.25%
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 35.71%
- EBON (EBON:NASDAQ), 35.24%
- Ignyta, Inc. (RXDX:NASDAQ), 33.11%
- Synthetic Biologics, Inc. (SYN:NYSEMKT), 29.72%
- Aemetis, Inc. (AMTX:NASDAQ), 25.33%
- PlayAGS, Inc. (AGS:NYSE), 23.3%
- CLPS Incorporation (CLPS:NASDAQ), 23.2%